Research Article

The Serum Analysis of Dampness Syndrome in Patients with Coronary Heart Disease and Chronic Renal Failure Based on the Theory of “Same Syndromes in Different Diseases”

Table 5

Differential metabolites existing in the serums of patients with CRF showing dampness syndrome compared to the serums of healthy subjects.

FormulaMetabolites

130.0630C6H10O32-oxo-3-Methylvaleric acid
169.9988C3H7O6PDihydroxyacetone phosphate
267.0968C10H13N5O4Adenosine
143.0582C6H9NO3Vinylacetylglycine
126.0429C5H6N2O2Imidazoleacetic acid
167.0582C8H9NO3Pyridoxal
142.0378C5H6N2O35-Hydroxymethyluracil
181.0739C9H11NO3L-Tyrosine
156.0171C5H4N2O4Orotic acid